Outnumbered yet needed: The Lung Cancer Nurse Specialist

McLaughlin‐Barrett, Sara

doi:10.1111/resp.13844

Cited by 4 publications

(8 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Although fewer than half of all institutions reported having an LCNS, particularly low case-volume institutions, the total FTE for all LCNS was better than previous estimates 9. Access to an LCNS is associated with increased treatment rates, reduced unplanned hospital admissions and improved addressing of patient needs including complex case navigation and emotional and psychological support 15–17. Specialist cancer nurses in Australia are well recognised in breast and prostate cancer with an estimated 400 breast cancer nurses and at least 50 prostate cancer nurses in Australia 18 19.…”

Section: Discussionmentioning

confidence: 99%

“…9 Access to an LCNS is associated with increased treatment rates, reduced unplanned hospital admissions and improved addressing of patient needs including complex case navigation and emotional and psychological support. [15][16][17] Specialist cancer nurses in Australia are well recognised in breast and prostate cancer with an estimated 400 breast cancer nurses and at least 50 prostate cancer nurses in Australia. 18 19 Federal commitment to fund five FTE LCNS in the 2021 Budget is welcome, but considering the burden of disease from lung cancer in Australia, the need for a significant uplift in the number of specialist lung cancer nurses remains.…”

Section: Impact From the Covid-19 Pandemicmentioning

confidence: 99%

See 1 more Smart Citation

Hospital-based multidisciplinary lung cancer care in Australia: a survey of the landscape in 2021

et al. 2022

View full text Add to dashboard Cite

IntroductionLung cancer is the leading cause of cancer death in Australia and has the highest cancer burden. Numerous reports describe variations in lung cancer care and outcomes across Australia. There are no data assessing compliance with treatment guidelines and little is known about lung cancer multidisciplinary team (MDT) infrastructure around Australia.MethodsClinicians from institutions treating lung cancer were invited to complete an online survey regarding the local infrastructure for lung cancer care and contemporary issues affecting lung cancer.ResultsResponses from 79 separate institutions were obtained representing 72% of all known institutions treating lung cancer in Australia. Most (93.6%) held a regular MDT meeting although recommended core membership was only achieved for 42/73 (57.5%) sites. There was no thoracic surgery representation in 17/73 (23.3%) of MDTs and surgery was less represented in regional and low case volume centres. Specialist nurses were present in just 37/79 (46.8%) of all sites. Access to diagnostic and treatment facilities was limited for some institutions. IT infrastructure was variable and most sites (69%) do not perform regular audits against guidelines. The COVID-19 pandemic has driven most sites to incorporate virtual MDT meetings, with variable impact around the country. Clinician support for a national data-driven approach to improving lung cancer care was unanimous.DiscussionThis survey demonstrates variations in infrastructure support, provision and membership of lung cancer MDTs, in particular thoracic surgery and specialist lung cancer nurses. This heterogeneity may contribute to some of the well-documented variations in lung cancer outcomes in Australia.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Impact From the Covid-19 Pandemicmentioning

confidence: 99%

Hospital-based multidisciplinary lung cancer care in Australia: a survey of the landscape in 2021

et al. 2022

View full text Add to dashboard Cite

show abstract

“…The intervention was quickly and successfully implemented first because the hospital already had a unit with NNs with the skills and experience necessary for remote cancer patient monitoring. Second, the pre-existing CAPRI App and organizational tools (such as protocol and clinical decision support) used to monitor patients receiving oral therapies were rapidly adapted by the network combining the medical and care teams [8,14,16]. The implementation of the intervention was unprecedented in this context of health crisis due to uncertainty about the duration of the study and the number of patients expected to be enrolled.…”

Section: Discussionmentioning

confidence: 99%

Nurse navigators’ telemonitoring for cancer patients with COVID-19: a French case study

Ferrua

Mathivon

Duflot-Boukobza

et al. 2021

Support Care Cancer

View full text Add to dashboard Cite

Purpose The Gustave Roussy Cancer Institute implemented a patient-reported outcome platform (CAPRI-COVID) for cancer patients with coronavirus disease 2019 to quarantine patients at home while ensuring monitoring of COVID-related symptoms and securing the care pathway. In this study, we described the CAPRI-COVID intervention, evaluated its use, and presented results of the tracking indicators with a focus on the nurse navigators' (NNs) activities and the experience of patients. Methods Data of 130 cancer patients with COVID-19 diagnosed from March 23 to June 5, 2020, were collected. Six COVIDrelated symptoms were monitored daily, either by the patient via the CAPRI mobile application (CAPRI App) or by NNs via telemonitoring. In the cases of worsening or new-onset symptoms, an automated alert was sent to the platform, and NNs could immediately consult an emergency physician for future course of action. Results All 130 patients (median age: 59 years; 59.2% female) were monitored during the study period. There were no deaths or admissions to the intensive care unit attributable to COVID-19; 7.8% of patients were hospitalized (excluding scheduled hospitalization), and 17.1% were admitted to the emergency department at least once during the monitoring period. NNs carried out 1412 regular monitoring calls (average of 10.9 calls per patient), while 55% of the patients downloaded the CAPRI App. Conclusions Most patients monitored with CAPRI-COVID were quarantined during the first wave of the pandemic. In addition to the CAPRI App, which helped limit phone calls, NNs played an essential role in patient management.

show abstract

“…The literature identifies specialist breast care nurses 3,4 and specialist prostate cancer nurses 5 who support a cancer patient's journey; however, there is a critical shortage of specialist lung cancer nurses globally. [6][7][8][9] This shortage reflects a deeply rooted, complex mix of factors, such as stigma 10 ; negative public perception of smoking combined with an attitude of "deservedness" of a lung cancer diagnosis 11 ; and nihilism, both on the part of the person with the disease 12 and those treating people with the disease. 13 Additionally, less comparative funding for research into lung cancer 14 limits resources for patients and health professionals in this field.…”

Section: Introductionmentioning

confidence: 99%

“…The relative paucity of evidence on the specialist lung cancer nurse role has resulted in significant variation in how the role has been established and implemented in different countries. [6][7][8][9] Often driven at the organization, hospital, or clinic level, this variation does not necessarily achieve optimal patient care for all. 26 There is an urgent need to identify the core components of the specialist lung cancer nurse role to achieve the best outcomes for people living with lung cancer and understand how these components, in view of other non-clinical responsibilities, might best function in practice.…”

Section: Introductionmentioning

confidence: 99%

Roles and practices of specialist lung cancer nurses: a scoping review protocol

Brunelli¹,

Ramis²,

Kynoch³

2022

JBI Evidence Synthesis

View full text Add to dashboard Cite

Objective: The objective of this scoping review is to map the available literature on the role of specialist lung cancer nurses. Introduction: The international literature acknowledges the importance of specialist cancer nurses who provide supportive care to patients. Historically, however, there has been a lack of consistent evidence to inform development and implementation of the role. Inclusion criteria: This review will consider quantitative and qualitative studies of any design or methodology that report on role characteristics or behaviors, practices, or activities, or other aspects of specialist lung cancer nurses in the acute care setting. Systematic reviews, professional body reports, as well as unpublished or published studies and reports will also be considered for inclusion. Textual or opinion papers will be excluded. Methods: This review will follow the JBI methodology for scoping reviews. Relevant papers from 2006 to 2022, in any language, will be searched for in the following databases and registries: MEDLINE (PubMed), CINAHL (EBSCO), Web of Science, Embase, and the Cochrane Register of Controlled Trials. Websites to be searched will include the World Health Organization, International Council of Nurses, and Agency for Healthcare Research and Quality. ProQuest Dissertations and Theses (ProQuest) and Grey Matters (CADTH) will be searched for unpublished literature. Results will be presented in tabular and narrative format and mapped according to the specified concepts of interest, as well as to the domains of practice for specialist nursing roles.

show abstract

Outnumbered yet needed: The Lung Cancer Nurse Specialist

Abstract: See cover image

Cited by 4 publications

References 4 publications

Hospital-based multidisciplinary lung cancer care in Australia: a survey of the landscape in 2021

Hospital-based multidisciplinary lung cancer care in Australia: a survey of the landscape in 2021

Nurse navigators’ telemonitoring for cancer patients with COVID-19: a French case study

Roles and practices of specialist lung cancer nurses: a scoping review protocol

Contact Info

Product

Resources

About